The device combines balloon dilation and drug delivery to uptake highly lipophilic drug, paclitaxel, which limits hyperactive cell proliferation and the fibrotic scar tissue generation that results in stricture recurrence. It localizes drug delivery through micro tissue separations created by balloon expansion, ensuring that circumferential drug effectively covers the stricture, enabling doctors to treat diseases related to urology. Urotronic's mission is to develop revolutionary technologies that will transform the urology market through better patient outcomes that are uniquely positioned for today's healthcare environment.